TY  - GEN
AU  - Sette,G
AU  - Salvati,V
AU  - Mottolese,M
AU  - Visca,P
AU  - Gallo,E
AU  - Fecchi,K
AU  - Pilozzi,E
AU  - Duranti,E
AU  - Policicchio,E
AU  - Tartaglia,M
AU  - Milella,M
AU  - De Maria,R
AU  - Eramo,A
TI  - Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer
SN  - 2041-4889
PY  - 2016///0412
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Biomarkers, Pharmacological
KW  - metabolism
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Cell Line, Tumor
KW  - Drug Evaluation, Preclinical
KW  - ErbB Receptors
KW  - genetics
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, SCID
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neoplastic Stem Cells
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Receptor, ErbB-2
KW  - Signal Transduction
KW  - Tyrosine
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/cddis.2015.217
ER  -